Skip to main content
SpringerLink
Log in

Assessment of Prognostic Factors in Follicular Lymphoma Patients

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Prognostic factors, including clinical, biological, and histological parameters, were assessed for 94 patients with follicular lymphomas at our institute. Follicular lymphomas constituted 7.7% (94/1208) of malignant lymphomas in this study. Eighteen patients were diagnosed with stage I follicular lymphoma, 20 with stage II, 23 with stage III, and 33 with stage IV. The cases of follicular lymphoma were subclassified as: follicular small cleaved cell lymphoma (FSC) in 20 cases, follicular mixed cell lymphoma (FMX) in 59 cases, and follicular large cell lymphoma (FLC) in 15 cases.The patients comprised 49 men and 45 women with a median age of 54 years (range, 25-84 years). The complete response rate was 76.5%, and the median survival time was 13 years. The expected 10-year overall survival and event-free survival rates were 61.9% and 38.2%, respectively. Univariate analysis identified the factors associated with poor survival as elevated serum lactate dehydrogenase (LDH) level (P < .0001), age of >60 (P < .0001), Ann Arbor stage III/IV (P < .01), and Eastern Cooperative Oncology Group performance status (PS) of 2 to 4 (P = .048). Multivariate analysis showed that LDH, age, and PS were independent predictors. After application of the International Prognostic Index (IPI), the 10-year survival rates for the low-risk, low-intermediate risk, high-intermediate risk and high-risk groups were 80.4%, 48.7%, 21.9%, and 0.0%, respectively. The differences among these groups were significant atP < .01.The IPI for aggressive non-Hodgkin’s lymphoma was found to be applicable to survival prediction for Japanese follicular lymphoma patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Freedman AS, Gribben JG, Nadler LM. High dose therapy and autologous stem cell transplantation in follicular non-Hodgkin’s lymphoma.Leuk Lymphoma. 1998;28:219–230.

    Article  CAS  PubMed  Google Scholar 

  2. Bierman PJ, Vose JM, Anderson JR, et al. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin’s lymphoma.J Clin Oncol. 1997;15:445–450.

    Article  CAS  PubMed  Google Scholar 

  3. Freedman AS, Ritz J, Neuberg D, et al. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin’s lymphoma.Blood. 1991;77:2524–2529.

    PubMed  CAS  Google Scholar 

  4. Gribben JG, Freedman AS, Neuberg D, et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.N Engl J Med. 1991;325:1525–1533.

    Article  CAS  PubMed  Google Scholar 

  5. Maloney DG, Grillo-Lopez AJ, White CA, et al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma.Blood. 1997;90:2188–2195.

    CAS  PubMed  Google Scholar 

  6. McLaughlin P, Grillo-Lopez AJ, Link BK, et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.J Clin Oncol. 1998;16:2825–2833.

    Article  CAS  PubMed  Google Scholar 

  7. Czuczman MS, Grillo-Lopez AJ, White CA, et al. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.J Clin Oncol. 1999;17:268–276.

    Article  CAS  PubMed  Google Scholar 

  8. A predictive model for aggressive non-Hodgkin’s lymphoma: the International Non-Hodgkin’s Lymphoma Prognostic Factors Project.N Engl J Med. 1993;329:987–994.

  9. Lopez-Guillermo A, Montserrat E, Bosch F, et al. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.J Clin Oncol. 1994;12:1343–1348.

    Article  CAS  PubMed  Google Scholar 

  10. Armitage JO,Weisenburger DD. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes: Non-Hodgkin’s Lymphoma Classification Project.J Clin Oncol. 1998;16:2780–2795.

    Article  CAS  PubMed  Google Scholar 

  11. Osada H, Seto M, Ueda R, et al. bcl-2 gene rearrangement analysis in Japanese B cell lymphoma; novel bcl-2 recombination with immunoglobulin kappa chain gene.Jpn J Cancer Res. 1989;80:711–715.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Mitani S,Aoki N, Mizutani S, et al. bcl-2 gene rearrangement analysis of Japanese follicular lymphomas by polymerase chain reaction in formalin-fixed, paraffin-embedded tissue specimens.Jpn J Cancer Res. 1993;84:37–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. The Non-Hodgkin’s Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage.Cancer. 1982;49:2112–2135.

    Article  Google Scholar 

  14. Cameron DA, Leonard RC, Mao JH, et al. Identification of prognostic groups in follicular lymphoma: the Scotland and Newcastle Lymphoma Group Therapy Working Party.Leuk Lymphoma. 1993;10:89–99.

    Article  CAS  PubMed  Google Scholar 

  15. Coiffier B, Bastion Y, Berger F, et al. Prognostic factors in follicular lymphomas.Semin Oncol. 1993;20:89–95.

    PubMed  CAS  Google Scholar 

  16. Katsumata N, Matsuno Y, Nakayama H, et al. Prognostic factors and a predictive model of follicular lymphoma: a 25-year study at a single institution in Japan.Jpn J Clin Oncol. 1996;26:445–454.

    Article  CAS  PubMed  Google Scholar 

  17. Lopez-Guillermo A, Montserrat E, Bosch F, et al. Low-grade lymphoma: clinical and prognostic studies in a series of 143 patients from a single institution.Leuk Lymphoma. 1994;15:159–165.

    Article  CAS  PubMed  Google Scholar 

  18. Romaguera JE, McLaughlin P, North L, et al. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.J Clin Oncol. 1991;9:762–769.

    Article  CAS  PubMed  Google Scholar 

  19. Wendum D, Sebban C, Gaulard P, et al. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma: Groupe d’Etude des Lymphomes de l’Adulte.J Clin Oncol. 1997;15:1654–1663.

    Article  CAS  PubMed  Google Scholar 

  20. Steward WP, Crowther D, McWilliam LJ, et al. Maintenance chlorambucil after CVP in the management of advanced stage, lowgrade histologic type non-Hodgkin’s lymphoma: a randomized prospective study with an assessment of prognostic factors.Cancer. 1988;61:441–447.

    Article  CAS  PubMed  Google Scholar 

  21. Bennett JM, Cain KC, Glick JH, et al. The significance of bone marrow involvement in non-Hodgkin’s lymphoma: the Eastern Cooperative Oncology Group experience.J Clin Oncol. 1986;4:1462–1469.

    Article  CAS  PubMed  Google Scholar 

  22. Cheson BD, Horning SJ, Coiffier B, et al. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin’s Lymphomas.J Clin Oncol. 1999;17:1244–1253.

    Article  CAS  PubMed  Google Scholar 

  23. Decaudin D, Lepage E, Brousse N, et al. Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients—a study of the Groupe d’Etude des Lymphomes de l’Adulte.J Clin Oncol. 1999;17:2499–2505.

    Article  CAS  PubMed  Google Scholar 

  24. Chen PM, Lin SH, Seto M, et al. Rearrangement of bcl-2 genes in malignant lymphomas in Chinese patients.Cancer. 1993;72:3701–3706.

    Article  CAS  PubMed  Google Scholar 

  25. Lopez-Guillermo A, Cabanillas F, McDonnell TI, et al. Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.Blood. 1999;93:3081–3087.

    PubMed  CAS  Google Scholar 

  26. Leonard RC, Hayward RL, Prescott RJ, et al. The identification of discrete prognostic groups in low grade non-Hodgkin’s lymphoma: the Scotland and Newcastle Lymphoma Group Therapy Working Party.Ann Oncol. 1991;2:655–662.

    Article  CAS  PubMed  Google Scholar 

  27. Lopez-Guillermo A, Cabanillas F, McLaughlin P, et al. The clinical significance of molecular response in indolent follicular lymphomas.Blood. 1998;91:2955–2960.

    PubMed  CAS  Google Scholar 

  28. Martinka M, Comeau T, Foyle A, et al. Prognostic significance of t(14;18) and bcl-2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma.Clin Invest Med. 1997;20:364–370.

    PubMed  CAS  Google Scholar 

  29. Martin AR,Weisenburger DD, Chan WC, et al. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma.Blood. 1995;85:3671–3678.

    PubMed  CAS  Google Scholar 

  30. Bartlett NL, Rizeq M, Dorfman RF, et al. Follicular large-cell lymphoma: intermediate or low grade?J Clin Oncol. 1994;12:1349–1357.

    Article  CAS  PubMed  Google Scholar 

  31. Salles G, Coiffier B. Histologic transformation in follicular lymphoma.Ann Oncol. 1998;9:803–805.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Chemotherapy, Nagoya, Japan

    Eisei Kondo, Michinori Ogura, Yoshitoyo Kagami, Hirohumi Taji, Kazuhisa Miura, Takahiro Takeuchi, Satoko Maeda, Shouji Asakura, Ritsuro Suzuki & Yasuo Morishima

  2. Department of Pathology and Genetics, Aichi Cancer Center Hospital, Nagoya, Japan

    Ritsuro Suzuki & Shigeo Nakamura

Authors
  1. Eisei Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michinori Ogura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshitoyo Kagami
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hirohumi Taji
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazuhisa Miura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takahiro Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Satoko Maeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shouji Asakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ritsuro Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shigeo Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yasuo Morishima
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Kondo, E., Ogura, M., Kagami, Y. et al. Assessment of Prognostic Factors in Follicular Lymphoma Patients. Int J Hematol 73, 363–368 (2001). https://doi.org/10.1007/BF02981963

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02981963

Key words

Search

Navigation